| Product NDC: | 67425-002 |
| Proprietary Name: | VITRASE |
| Non Proprietary Name: | hyaluronidase, ovine |
| Active Ingredient(s): | 200 [USP'U]/mL & nbsp; hyaluronidase, ovine |
| Administration Route(s): | SUBCUTANEOUS |
| Dosage Form(s): | INJECTION, SOLUTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 67425-002 |
| Labeler Name: | ISTA Pharmaceuticals, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA021640 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20050201 |
| Package NDC: | 67425-002-10 |
| Package Description: | 2 mL in 1 VIAL, GLASS (67425-002-10) |
| NDC Code | 67425-002-10 |
| Proprietary Name | VITRASE |
| Package Description | 2 mL in 1 VIAL, GLASS (67425-002-10) |
| Product NDC | 67425-002 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | hyaluronidase, ovine |
| Dosage Form Name | INJECTION, SOLUTION |
| Route Name | SUBCUTANEOUS |
| Start Marketing Date | 20050201 |
| Marketing Category Name | NDA |
| Labeler Name | ISTA Pharmaceuticals, Inc. |
| Substance Name | HYALURONIDASE, OVINE |
| Strength Number | 200 |
| Strength Unit | [USP'U]/mL |
| Pharmaceutical Classes | Endoglycosidase [EPC],Glycoside Hydrolases [Chemical/Ingredient] |